Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Cited by (1,001)

Items 701–800 of 1,001

1. The race for a COVID-19 vaccine: where are we up to?
   Md Kamal Hossain, Majid Hassanzadeganroudsari, Jack Feehan, Vasso Apostolopoulos · 2021 · Expert Review of Vaccines
2. Vaccination for SARS-CoV-2 in Hematological Patients
   Niccolò Riccardi, Marco Falcone, Dafna Yahav · 2022 · Acta Haematologica
3. ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia
   Jason H. Karnes, Jérôme Rollin, Jason B. Giles, Kiana L. Martinez, Heidi E. Steiner, Christian M. Shaffer, Yukihide Momozawa, Chihiro Inai, Andrei Bombin, Mingjian Shi et al. · 2022 · Blood
4. The current status of COVID-19 vaccines. A scoping review
   Manuel Rueda-Fernández, Lucía Melguizo‐Rodríguez, Victor Javier Costela-Ruiz, Anabel González‐Acedo, Javier Ramos‐Torrecillas, Rebeca Illescas Montes · 2022 · Drug Discovery Today
5. Heparin‐Induced Thrombocytopenia
   Theodore Earl Warkentin, Andreas Greinacher · 2022
6. Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
   Om Prakash Choudhary, Priyanka Choudhary, Jivan Qasim Ahmed, Teroj Abdulrahman Mohammed, Indraj Singh, Alfonso Javier Rodriguez-Morales · 2021 · Human Vaccines & Immunotherapeutics
7. COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan
   Balraj Singh, Parminder Kaur, Vinod Kumar, Michael Maroules · 2021 · Radiology Case Reports
8. Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
   Rumiko Shimazawa, Masayuki Ikeda · 2021 · Journal of Pharmaceutical Policy and Practice
9. COVID-19 and Kounis Syndrome: Deciphering Their Relationship
   Nicholas George Kounis, Ioanna C. Koniari, Cesare DE GREGORIO · 2021 · Balkan Medical Journal
10. Organ transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia
    George H. B. Greenhall, Ines Ushiro‐Lumb, Sue R. Pavord, Ian S. Currie, M. Thamara P. R. Perera, Hermien Hartog, Quentin A. Hill, Ismail Mohamed, Muhammad Arslan Khurram, Reza Motallebzadeh et al. · 2021 · American Journal of Transplantation
11. COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism
    R -L Wang, W -F Chiang, H -Y Shyu, M -H Chen, C -I Lin, K -A Wu, C -C Yang, L -Y Huang, Po-Jen Hsiao · 2021 · QJM
12. Perioperative Coronavirus Vaccination—Timing and Implications: A Guidance Document
    HelenMari Merritt-Genore, Rainer Moosdorf, Erin Alexis Gillaspie, Sylvain Lother, Daniel T. Engelman, Shahnur Ahmed, Frank Alexander Baciewicz, Michael Conrad Grant, Rita Carrie Karianna Milewski, Kelly A. Cawcutt et al. · 2021 · The Annals of Thoracic Surgery
13. Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
    Hye‐Rim Shin, Baik-Kyun Kim, Soon‐Tae Lee, Aryun Kim · 2022 · Journal of Clinical Neurology
14. Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA–1273 vaccine: A case report
    Yuya Kamura, Toshiki Terao, Satoshi Akao, Yumi Kono, Koichi Honma, Kosei Matsue · 2022 · International Journal of Infectious Diseases
15. mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People
    Anna Rosa Garbuglia, Claudia Minosse, Paola Del Porto · 2022 · Viruses
16. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia
    Yumei Liu, Zonghong Shao, Huaquan Wang · 2021 · Thrombosis Research
17. COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion
    Davide Romano, Francesco Morescalchi, Vito Romano, Francesco Semeraro · 2022 · Ocular Immunology and Inflammation
18. Influenza vaccination features revealed by a single‐cell transcriptome atlas
    Yi Wang, Xiaoxia Wang, Xinbei Jia, Jieqiong Li, Jin Xiang Fu, Xiaolan Huang, Xiaodai Cui, Bike Wang, Wenkai Luo, Chengcong Lin et al. · 2022 · Journal of Medical Virology
19. SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders
    Shubhra Khare, Niharika Niharika, Ajey Singh, Imtiyaz Hussain, N. B. Singh, Subhash C. Singh · 2022 · Applied Biochemistry and Biotechnology
20. SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis
    A Ram Lee, Jin Seok Woo, Seon-Yeong Lee, Yeon Su Lee, Jooyeon Jung, Chae Rim Lee, Sung‐Hwan Park, Mi‐La Cho · 2023 · Cell Communication and Signaling
21. Real-world data on the incidence and risk of Guillain–Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study
    Jongmok Ha, Suyeon Park, Hyunwook Kang, Taeeun Kyung, Namoh Kim, Dong‐Kyu Kim, Hyeonjoon Kim, Kihoon Bae, Min Cheol Song, Kwang June Lee et al. · 2023 · Scientific Reports
22. Cerebrovascular Disease in COVID-19
    James Ernest Siegler, Savanna Dasgupta, Mohamad K. Abdalkader, Mary Penckofer, Shadi R. Yaghi, Thanh Ngoc Nguyen · 2023 · Viruses
23. Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group
    Rebecca E. Chandler, Madhava Ram Balakrishnan, Daniel J. Brasseur, Philip T. Bryan, Emmanuelle Espié, Katharina Hartmann, Corinne Jouquelet‐Royer, James Milligan, Linda Nesbitt, Shanthi Narayan Pal et al. · 2024 · BMJ Global Health
24. Vaccine against COVID-19
    Juan Jose Picazo · 2021 · Revista Española de Quimioterapia
25. Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report
    Martin Koch, Sybille Fuld, Jan Moritz Middeke, Julia Fantana, Simone von Bonin, Jan Beyer‐Westendorf · 2021 · TH Open
26. Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination
    Noppacharn Uaprasert, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Sasinipa Trithiphen, Benjaporn Akkawat, Autcharaporn Sukperm, Thanisa Tongbai, Watsamon Jantarabenjakul, Leilani Paitoonpong, Ponlapat Rojnuckarin · 2021 · Research and Practice in Thrombosis and Haemostasis
27. Evaluation of Adverse Reactions to Vaccines
    Anne Des Roches, François James Graham, Philippe Bégin, Louis P. Paradis, Michael Gold · 2021 · The Journal of Allergy and Clinical Immunology In Practice
28. Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India
    Boby Varkey Maramattom, Fathima Mihta Moidu, Sajira K. Varikkottil, Akheel A. Syed · 2021 · BMJ Case Reports
29. COVID-19 and thrombosis: searching for evidence
    Bright Thilagar, Mohamad H. Beidoun, Ruben Rhoades, Scott S. Kaatz · 2021 · Hematology
30. Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
    Ulrika Wimmercranz Marking, Sebastian Havervall, Nina Greilert‐Norin, Henry Ng, Kim G. Blom, Peter Nilsson, Mia Phillipson, Sophia Hober, Charlotta Nilsson, Sara M. Mangsbo et al. · 2022 · Vaccines
31. Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review
    Diana Aguiar de Sousa, Michele Romoli, Mayte Sánchez van Kammen, Mirjam R. Heldner, Andrea Zini, Jonathan M. Coutinho, Marcel Arnold, José Manuel Ferro · 2022 · Stroke
32. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland
    Anna Paczkowska, Karolina Hoffmann, Michał Michalak, Anna Hans-Wytrychowska, Wiesław Bryl, Dorota Kopciuch, Tomasz Zaprutko, Piotr Ratajczak, Elżbieta Nowakowska, Krzysztof Kus · 2022 · Vaccines
33. Perceived risk and vaccine hesitancy: Quasi-experimental evidence from Italy
    Gianluca Mazzarella · 2022 · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
34. Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
    Cédric Garcia, Baptiste Compagnon, Michaël Poette, Marie‐Pierre Gratacap, François-Xavier Lapébie, Sophie Voisin, Vincent Minville, Bernard Payrastre, Fanny Vardon Bounes, Agnès Maurel Ribes · 2022 · Cells
35. Autopsy findings of post-COVID-19 vaccination deaths in Tokyo Metropolis, Japan, 2021
    Hideto Suzuki, Ayako Ro, Aya Takada, Kazuyuki Saito, Kino Hayashi · 2022 · Legal Medicine
36. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks
    Abdolreza Esmaeilzadeh, Armin Jahani Maleki, Amirhosein Moradi, Amir Siahmansouri, Mohammad Javad Yavari Barhaghtalab, Parsa Karami, Reza Elahi · 2022 · Expert Review of Vaccines
37. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors
    Mengqi Xiang, Xiaoming Wu, Haijiao Jing, Langjiao Liu, Chunxu Wang, Yufeng Wang, Valerie Anne Novakovic, Jialan Shi · 2022 · Frontiers in Immunology
38. COVID vaccines and blood clots: what researchers know so far
    Heidi K. Ledford · 2021 · Nature
39. Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination
    Hakjun Hyun, Joon Young Song, Hye Seong, Jin Gu Yoon, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim · 2021 · Journal of Korean Medical Science
40. Deterioration of vaccine‐induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay
    ALICE BEREZNE, David Bougon, Florence Blanc‐Jouvan, Nicolas Gendron, Cécile Janssen, Michel Müller, Sébastien Bertil, Florence Desvard, Isabelle Présot, Benjamin Terrier et al. · 2021 · Research and Practice in Thrombosis and Haemostasis
41. Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination
    Ammar Waraich, George Williams · 2021 · BMJ Case Reports
42. Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT)
    Luke Flower, Zdenek Bares, Georgina Santiapillai, Steve K. Harris · 2021 · BMJ Case Reports
43. Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
    Robert Daniel Heinrich Markewitz, David Juhl, Daniela Pauli, Siegfried Görg, Ralf Junker, Jan Rupp, Sarah Engel, Katja Steinhagen, Victor Herbst, Dorinja Zapf et al. · 2022 · Frontiers in Immunology
44. Non-clinical immunogenicity, biodistribution and toxicology evaluation of a chimpanzee adenovirus-based COVID-19 vaccine in rat and rhesus macaque
    Xuedong Dai, Weijun Zhao, Xin Tong, Wei Yong Liu, Xianhuan Zeng, Xiaohui Duan, Hua Wu, Lili Wang, Zhen Jian Huang, Xin‐Ying Tang et al. · 2022 · Archives of Toxicology
45. Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
    Christy Varghese John, Rajesh Kumar, Anil Kumar Sivan, Sangeetha Jithin, Rojin G. Abraham, Chepsy Cherian Philip · 2022 · Thrombosis Journal
46. Thrombotic events following Covid-19 vaccines compared to Influenza vaccines
    Marcelo Gabriel Vallone, Andre Luis Falcón, Horacio Matías Castro, Augusto Ferraris, Ramiro Francisco Cantarella, María Inés Staneloni, Valeria Ines Aliperti, Analía Ferloni, Daniela Mezzarobba, Fernando Javier Vázquez et al. · 2022 · European Journal of Internal Medicine
47. Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey
    Vittorio Pengo, Teresa Del Ross, Marta Tonello, Laura Andréoli, Anǵela Tincani, Paolo Gresele, Elena Silvestri, Paolo Simioni, Elena Campello, Ariela Hoxha et al. · 2022 · Lara D. Veeken
48. Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland
    Paul McKeigue, Raj Burgul, Jen Bishop, Chris Robertson, Jim McMenamin, Maureen O’Leary, David McAllister, Helen Martina Colhoun · 2021 · BMC Infectious Diseases
49. mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
    Eric Yuk Fai Wan, Celine Sze Ling Chui, Anna Hoi Ying Mok, Wanchun Xu, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Xue Li, Carlos King Ho Wong, Esther W. Chan, David Tak Wai Lui et al. · 2022 · Drug Safety
50. Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
    Venkata A. S. Dabbiru, Luisa Müller, Linda Schönborn, Andreas Greinacher · 2023 · Journal of Clinical Medicine
51. Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination
    Melissa Klug, Olga Lazareva, Kilian Kirmes, Marc Rosenbaum, Marina Lukas, Simon Weidlich, Christoph D. Spinner, Moritz von Scheidt, Rosanna Gosetti, Jan Baumbach et al. · 2021 · Thrombosis and Haemostasis
52. Hypercoagulability of COVID-19 and Neurological Complications: A Review
    PATRICK J. MOORE, Fatema Esmail, Shuai Qin, Sucha Nand, Stephanie A Berg · 2021 · Journal of Stroke and Cerebrovascular Diseases
53. Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases
    Jonathan Cleaver, Richard Tolulope Ibitoye, Hamish Duncan Morrison, Richard Flood, Kate Crewdson, Aidan Marsh, Kumar Abhinav, Rose Bosnell, Robert A. Crossley, Alex Mark Mortimer · 2021 · Journal of NeuroInterventional Surgery
54. Coronary thrombo-embolic events after Covid-19 vaccination- a single centre study
    Refai Showkathali, Radhapriya Yalamanchi, Narra Lavanya, Nandhini Vinayagamoorthy, Sengottuvelu Gunasekaran, Rajeshwari Nayak, Y. Vijayachandra Reddy, Asha Mahilmaran, Srinivasan Kanthallu Narayanamoorthy, Abraham Oomman et al. · 2022 · Indian Heart Journal
55. Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenic role of ChAdOx1 nCoV-19 vaccine-encoded soluble SARS-CoV-2 spike protein
    Manuela De Michele, Paola Piscopo, Alessio Crestini, Roberto Rivabene, Giulia d’Amati, Martina Leopizzi, Lucia Stefanini, Fabio Maria Pulcinelli, Antonio Chistolini, Marta Iacobucci et al. · 2022 · Haematologica
56. Longitudinal Aspects of VITT
    Linda Schönborn, Andreas Greinacher · 2022 · Seminars in Hematology
57. Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
    Caroline H. K. Dix, James D. McFadyen, Angela Huang, Sanjeev Daya Chunilal, Vivien Mun Yee Chen, Huyen Anh Tran · 2022 · Internal Medicine Journal
58. The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies
    Caroline Vayne, Raghavendra Palankar, Sandra Billy, Stefan Handtke, Thomas Thiele, Charlotte Cordonnier, Claire Pouplard, Andreas Greinacher, Yves Gruel, Jérôme Rollin · 2022 · Haematologica
59. Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology
    Madhumita Chatterjee · 2022 · Cells
60. Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months
    Samantha J. Montague, Christopher W. Smith, Clare S. Lodwick, Charlotte Stoneley, Matthew Roberts, Gillian Lowe, Will Lester, Steve P. Watson, Phillip L.R. Nicolson · 2022 · Research and Practice in Thrombosis and Haemostasis
61. Comparison of COVID-19 Pandemic Waves in 10 Countries in Southern Africa, 2020–2021
    Joshua Smith-Sreen, Bridget M. Miller, Alinune Nathanael Kabaghe, Andrea A. Kim, Nellie Wadonda-Kabondo, Alean A. Frawley, Sarah M. Labuda, Eusébio Manuel, Helga Frietas, Anne Mwale et al. · 2022 · Emerging infectious diseases
62. Being Bayesian in the 2020s: opportunities and challenges in the practice of modern applied Bayesian statistics
    Joshua J. Bon, Adam Bretherton, Katie Buchhorn, Susanna M. Cramb, Christopher Drovandi, Conor Hassan, Adrianne L. Jenner, Helen J. Mayfield, James M. McGree, Kerrie Lee Mengersen et al. · 2023 · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences
63. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19
    Nevio Cimolai · 2021 · SN Comprehensive Clinical Medicine
64. Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy
    Guillaume Costentin, Ozlem Ozkul-Wermester, Aude Bagan Triquenot, Véronique Le Cam‐Duchez, Nathalie Massy, Y. Benhamou, Evelyne Massardier · 2021 · Journal of Stroke and Cerebrovascular Diseases
65. Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female
    Ranjit Babu Jasaraj, Dhan Bahadur Shrestha, Suman Gaire, Mohammed Azher Kassem · 2021 · Cureus
66. A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management
    Raghavendra Kotal, Ipe Jacob, Pradeep Rangappa, Karthik Rao, Guruprasad Hosurkar, Satish Kumar Anumula, Avinasha M. Kuberappa · 2021 · Surgical Neurology International
67. Immune Responses against SARS-CoV-2—Questions and Experiences
    Harald Mangge, Markus Kneihsl, Wolfgang Johann Schnedl, Gerald Sendlhofer, Francesco Curcio, Rossana Domenis · 2021 · Biomedicines
68. Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2
    Edelgard Lindhoff‐Last, Linda Schönborn, Michael Piorkowski, Joerg Herold, Andreas Greinacher, Jo‐Ann I. Sheppard, Theodore Earl Warkentin · 2021 · Thrombosis and Haemostasis
69. SARS‐CoV‐2‐related and Covid‐19 vaccine‐induced thromboembolic events: A comparative review
    Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, Seyed Rouhollah Miri, Terence Tai Weng Sio, Mark J. M. Sullman, Kristin Carson‐Chahhoud, Florian Peter Länger et al. · 2022 · Reviews in Medical Virology
70. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome
    Flávio Signorelli, Gustavo Guimarães Moreira Balbi, Nádia Emi Aikawa, Clóvis A. Silva, Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Carla Gonçalves Schahin Saad, Eduardo Ferreira Borba et al. · 2022 · Lupus
71. Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares
    Francesco Carubbi, Alessia Alunno, Jessica Santilli, Laura Natali, Bernardina Mancini, Nicoletta Di Gregorio, Rita Del Pinto, Angelo Viscido, Davide Grassi, Claudio Ferri · 2022 · RMD Open
72. Evaluation of the T cell and B cell response following the administration of COVID-19 vaccines in Korea
    Kristin Widyasari, Jieun Jang, Seung Jun Lee, Taejoon Kang, Sun‐Joo Kim · 2022 · Journal of Microbiology Immunology and Infection
73. Mucosal delivery of nanovaccine strategy against COVID-19 and its variants
    Junwoo Lee, Dongwoo Khang · 2022 · Acta Pharmaceutica Sinica B
74. Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT)
    Nikita Cliff-Patel, Lindsay Moncrieff, Veqas Ziauddin · 2021 · European Journal of Case Reports in Internal Medicine
75. Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity
    Rhiane Moody, Kirsty Wilson, Jennifer C. Boer, Jessica K. Holien, Katie L. Flanagan, Anthony Jaworowski, Magdalena Plebanski · 2021 · Frontiers in Bioinformatics
76. Post COVID-19 vaccine deaths - Singapore’s early experience
    Audrey Yeo, Benjamin Kuek, Mandy LAU, Shi Rui Tan, Shijia Chan · 2022 · Forensic Science International
77. Fulminant myocarditis in a patient with a lung adenocarcinoma after the third dose of modern COVID-19 vaccine. A case report and literature review
    E. Terán Brage, Jonnathan Roldán-Ruiz, Javier González Martín, Juan Diego Oviedo Rodríguez, Rosario Vidal Tocino, Sara Rodríguez Diego, Pedro Luis Sánchez Hernández, Lorena Bellido Hernández, Emilio Fonseca Sánchez · 2022 · Current Problems in Cancer Case Reports
78. Case Report: Recanalization of Branch Retinal Artery Occlusion Due to Microthrombi Following the First Dose of SARS-CoV-2 mRNA Vaccination
    Min Seung Kang, Sang Yoon Kim, Han Jo Kwon · 2022 · Frontiers in Pharmacology
79. VITT with inactivated SARS-CoV-2 vaccine – index case
    Kanta Devi, Natasha Bahadur Ali, Nosheen Nasir, Syed Faisal Mahmood · 2022 · Human Vaccines & Immunotherapeutics
80. Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway
    Farid Salih, Siegfried Köhler, Linda Schönborn, Thomas Thiele, Andreas Greinacher, Matthias Endres · 2022 · European Heart Journal Open
81. At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
    Singanallur, Nagendrakumar B., van Vuren, Petrus Jansen, McAuley, Alexander J., Bruce, Matthew P., Kuiper, Michael J., Gwini, Stella M., Riddell, Shane, Goldie, Sarah, Drew, Trevor W., Blasdell, Kim R. et al. · 2022 · Frontiers in Immunology
82. Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine
    Flordeluna Z Mesina · 2022 · Hematology Transfusion and Cell Therapy
83. New insights into human immune memory from SARS‐CoV ‐2 infection and vaccination
    Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Allergy
84. Myocardial infarction following COVID-19 vaccine administration; a systematic review
    Dana Hama-Baqi Mohammed-Saeed, Fahmi H. Kakamad, Zana H. Mahmood, Fattah H. Fattah, Shaho Fatah Ahmed, Marwan Nasih Hassan, Bnar J. Hama Amin, Shvan Hussein Mohammed, Tomas M. Mikael, Hunar Ali Hassan et al. · 2022 · Heliyon
85. Waning of humoral immunity depending on the types of COVID-19 vaccine
    So Yun Lim, Ji Yeun Kim, Jiwon Jung, Sung‐Cheol Yun, Sung‐Han Kim · 2023 · Scandinavian Journal of Infectious Diseases
86. Incidence and management of the main serious adverse events reported after COVID ‐19 vaccination
    Teresa Padilla‐Flores, Alicia Sampieri, Luis A. Vaca · 2024 · Pharmacology Research & Perspectives
87. The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia
    Theodore Earl Warkentin, Menaka Pai · 2022 · Annals of Internal Medicine
88. A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital
    Asmat, Huma, Fayeye, Folusho, Alshakaty, Hameed, Patel, Jay · 2021 · BMJ Case Reports
89. AZD1222 vaccine‐related coagulopathy and thrombocytopenia without thrombosis in a young female
    Eileen Ryan, Dalyia Benjamin, Ian McDonald, Aisling Barrett, Johnny McHugh, Kevin M. Ryan, Helen Enright · 2021 · British Journal of Haematology
90. A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization
    Nathaniel Edward Wiest, Gretchen Schaef Johns, Eric Edwards · 2021 · Vaccines
91. Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic
    Thomas Theo Brehm, Michelle Thompson, Felix Ullrich, Dorothee Schwinge, Marylyn M. Addo, Anthea Spier, Johannes K.‐M. Knobloch, Martin Aepfelbacher, Ansgar Wilhelm Lohse, Marc Lütgehetmann et al. · 2021 · International Journal of Hygiene and Environmental Health
92. Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination
    Yohsuke Yagi, Yutaro Asami, Mitsuki Kyoya, Takanori Yokota · 2021 · Neurological Sciences
93. Bilateral acute macular neuroretinopathy in a young woman after the first dose of Oxford–AstraZeneca COVID-19 vaccine
    Pierre‐Henry Gabrielle, Florian Baudin, Inès Ben Ghezala, Cyril Meillon, Alain Marie Bron, Louis Arnould, Catherine P Creuzot-Garcher · 2022 · American Journal of Ophthalmology Case Reports
94. Two Cases of Acute Macular Neuroretinopathy Associated with the Adenovirus-based COVID-19 Vaccine Vaxzevria (Astrazeneca)
    Alexander Franchi, Teresa Rauchegger, Christoph Palme, Katharina Frede, Gertrud Haas, Georgios Blatsios, Martina Theresa Kralinger, Claus Zehetner · 2022 · Ocular Immunology and Inflammation
95. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines
    Mohamed Sadek Abdel‐Bakky, Elham Amin, Mohamed G. Ewees, Nesreen Ishak Mahmoud, Hamdoon Abdelhamid Mohammed, Waleed M. Altowayan, Ahmed A. H. Abdellatif · 2022 · Viruses
96. Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities
    Shelan Liu, Min Kang, Na Zhao, Yali Zhuang, Shijian Li, Tie Song · 2022 · Medical Review
97. Possible COVID-19 MRNA Vaccine-Induced Case of Unilateral Central Retinal Vein Occlusion
    Ágnes Ildikó Takács, Mónika Ecsedy, Zoltán Zsolt Nagy · 2022 · Ocular Immunology and Inflammation
98. Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia
    Victoria Panagiota, Christiane E. Dobbelstein, Sonja Werwitzke, Arnold Ganser, Nina Cooper, Ulrich J. Sachs, Andreas Tiede · 2022 · Viruses
99. Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review
    Rana I. Oueijan, Olivia R. Hill, Peter D. Ahiawodzi, Pius S. Fasinu, Dorothea K. Thompson · 2022 · Medicines
100. Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
     Jahnavi Gollamudi, Sarah E. Sartain, Amir Navaei, Satinder Aneja, Pawandeep Kaur Dhawan, Dat Thien Tran, Jyoti Joshi, Jane Gidudu, Jayakrishna Gollamudi, Elena Chiappini et al. · 2022 · Vaccine